Fri, April 8, 2022
Thu, April 7, 2022
Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022

Balaji Prasad Upgraded (TEVA) to Buy and Increased Target to $13 on, Apr 5th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-increased-target-to-13-on-apr-5th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Balaji Prasad of Barclays, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy and Increased Target from $11 to $13 on, Apr 5th, 2022.

Balaji has made no other calls on TEVA in the last 4 months.



There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, all agrees with Balaji's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, January 27th, 2022

Publication Contributing Sources